Randall Children's Hospital

Portland, Oregon 97227

5 studies enrolling now · 11 studies all time

What they study most

ADH Inappropriate, Choroid Plexus Neoplasms, Clear Cell Sarcoma, Craniopharyngioma, Dysembryoplastic Neuroepithelial Tumor, Ependymoma, Ewings Sarcoma, Fluid and Electrolyte Imbalance, Germ Cell Tumors, Glioma, Immune Thrombocytopenia, Intravenous Fluids

Studies at this site

• Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma — Recruiting now
• Pediatric Precision Laboratory Advanced Neuroblastoma Therapy — Recruiting now
• DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma — Recruiting now
• Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma — Recruiting now
• Beat Childhood Cancer Specimen Banking and Data Registry — Recruiting now
• Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma — Running, not enrolling
• Neuroblastoma Maintenance Therapy Trial — Running, not enrolling
• Molecular-Guided Therapy for Childhood Cancer — Completed
• Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children — Completed
• SOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric Patients — Completed
• Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) — Completed